Alterity Therapeutics (PRNAD) Other Non Operating Income (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Other Non Operating Income for 11 consecutive years, with $12282.6 the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non Operating Income rose 107.28% year-over-year to $12282.6; the TTM figure through Dec 2025 stood at -$449955.0 (up 66.67% YoY), while the FY2025 annual figure was -$42980.1, up 100.0% from the prior year.
• Other Non Operating Income came in at $12282.6 for Q4 2025 at Alterity Therapeutics, up from -$168754.2 in the prior quarter.
• The five-year high for Other Non Operating Income was $12282.6 in Q4 2025, with the low at -$887856.6 in Q4 2021.
• Average Other Non Operating Income over 5 years is -$267562.3, with a median of -$168754.2 recorded in 2024.
• Across the five-year window, Other Non Operating Income plunged 7673.09% in 2024 and surged 107.28% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at -$887856.6 in 2021, then jumped by 66.69% to -$295711.7 in 2022, then surged by 100.75% to $2228.3 in 2023, then slumped by 7673.09% to -$168754.2 in 2024, then jumped by 107.28% to $12282.6 in 2025.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $12282.6, -$168754.2, and $2228.3 for Q4 2025, Q4 2024, and Q4 2023 respectively.